January 2022

Models of clinical care delivery for geriatric oncology in Canada and the United States: A survey of geriatric oncology care providers

Lina Silva Salinas2022-01-31T08:09:26+01:00

Catalina Hernandez-Torres, Beatriz Korc-Grodzicki, Tina Hsu. Published:January 29, 2022 DOI:https://doi.org/10.1016/j.jgo.2022.01.004

Models of clinical care delivery for geriatric oncology in Canada and the United States: A survey of geriatric oncology care providersLina Silva Salinas2022-01-31T08:09:26+01:00

Systemic treatment for triple negative breast cancer in older patients: A Young International Society of Geriatric Oncology Review Paper

Lina Silva Salinas2022-01-24T08:26:04+01:00

Wing-Lok Chan, Joana Marinho, Yanin Chavarri-Guerra, Jacobo Hincapie-Echeverri, Rogelio N. Velasco, Baran Akagunduz, Mukul Roy, Wing Tung Gobby Kwong, Wing-Fong Wu, Nicolò Matteo Luca Battisti, Enrique Soto-Perez-de-Celis.Journal of Geriatric Oncology. Available online 23 January 2022

Systemic treatment for triple negative breast cancer in older patients: A Young International Society of Geriatric Oncology Review PaperLina Silva Salinas2022-01-24T08:26:04+01:00

Care provided by older adults in active cancer treatment to a spouse: A scoping review

Lina Silva Salinas2022-01-11T09:12:50+01:00

Valentina Donison, Helen Yang, Ana Patricia Ayala, Aria Wills, Shabbir M.H. Alibhai, Martine Puts. Published: January 10, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.01.003

Care provided by older adults in active cancer treatment to a spouse: A scoping reviewLina Silva Salinas2022-01-11T09:12:50+01:00

Wearable sensors and at-home biospecimen collection supports older adults participation in clinical trials
Gallery

Wearable sensors and at-home biospecimen collection supports older adults participation in clinical trials

Lina Silva Salinas2022-01-31T08:06:53+01:00

Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.

Wearable sensors and at-home biospecimen collection supports older adults participation in clinical trialsLina Silva Salinas2022-01-31T08:06:53+01:00

Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years.

Lina Silva Salinas2022-01-13T11:08:31+01:00

Demetris Papamichael, Guilherme S. Lopes, Curt L. Olswold, Jean-Yves Douillard, Richard A. Adams, Timothy S. Maughan, Eric Van Cutsem, Alan P. Venook, Heinz-Josef Lenz, Volker Heinemann, Richard Kaplan, Carsten Bokemeyer, Benoist Chibaudel, Axel Grothey, Takayuki Yoshino, John Zalcberg, Aimery De Gramont, Qian Shib. Eur J Cancer 2022; 163: 1-15

Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years.Lina Silva Salinas2022-01-13T11:08:31+01:00

Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer – Results from a prospective phase IV clinical trial

Lina Silva Salinas2022-01-04T09:29:02+01:00

Johannes Betge, Nadine Schulte, Sebastian Belle, Tianzuo Zhan, Beate Krammer-Steiner, Jean-Charles Moulin, Matthias Kleiß, Frank Lammert, Ulrich Wedding, Sebastian Räth, Martin Maenz, Lisa Hegele, Julian Larcher-Senn, Ralf Jesenofsky, Matthias P. Ebert, Nicolai Härtel. Published: January 03, 2022 DOI: https://doi.org/10.1016/j.jgo.2021.12.018.

Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer – Results from a prospective phase IV clinical trialLina Silva Salinas2022-01-04T09:29:02+01:00

Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myeloma

Lina Silva Salinas2021-12-20T08:15:04+01:00

Smith Giri, Sumit Dahal, Susan Bal, Kelly N. Godby, Joshua Richman, Adam J. Olszewski, Grant R. Williams, Cynthia Brown, Thomas W. Buford, Luciano J. Costa, Smita Bhatia. Published: December 17, 2021 DOI: https://doi.org/10.1016/j.jgo.2021.12.004

Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myelomaLina Silva Salinas2021-12-20T08:15:04+01:00

Monthly Archives: January 2022

SIOG Head Office

ECOSOC Special

Quick links

Stay in the loop with SIOG’s newsletter!